[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335514-105":59,"doc-detail-335514-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","long-term-exposure-to-antihypertensive-drugs-and-the-risk-of-cancer-occurrence-evidence-from-a-large-population-based-study","Long-term exposure to antihypertensive drugs and the risk of cancer occurrence - evidence from a large population-based study","","Objective: Available evidence on antihypertensive drugs and cancer risk often relies on short follow-up, limiting assessment of long-term effects. Methods: Using Lombardy (Italy) healthcare utilization databases, individuals aged 40–85 without prior cancer newly dispensed major antihypertensive classes (2009–2011) were followed to December 31, 2020, using first-drug and intention-to-treat analyses plus as-treated exposure changes. Adjusted Cox models evaluated duration-specific risk. Results: No consistent associations were seen for ACEIs, ARBs, or thiazides, while weak progressive increases emerged for calcium channel blockers and, in long-term exposure, beta-blockers. Conclusions: Long-term evaluation showed weak, class-specific cancer associations but no consistent signal for several major classes.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/long-term-exposure-to-antihypertensive-drugs-and-the-risk-of-cancer-occurrence-evidence-from-a-large-population-based-study/335514/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/long-term-exposure-to-antihypertensive-drugs-and-the-risk-of-cancer-occurrence-evidence-from-a-large-population-based-study/335514.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main aim of the study?","Question",{"text":112,"@type":113},"To assess whether long-term exposure to antihypertensive drugs is associated with the risk of cancer occurrence, addressing limitations of shorter follow-up in prior evidence.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were participants and drug exposure handled in the analysis?",{"text":117,"@type":113},"Individuals without prior cancer newly dispensed major antihypertensive drug classes (2009–2011) were followed to December 31, 2020, using both intention-to-treat and as-treated approaches that accounted for changes in exposure during follow-up.",{"name":119,"@type":110,"acceptedAnswer":120},"Which antihypertensive drug classes showed associations with cancer risk?",{"text":121,"@type":113},"No consistent significant association was found for ACE inhibitors, ARBs, or thiazides. Weak progressive increases in cancer occurrence were linked to calcium channel blockers and, limited to long-term exposure, to beta-blockers; modest increases for some diuretics appeared only in the as-treated approach.",{"name":123,"@type":110,"acceptedAnswer":124},"What conclusion did the authors draw about long-term exposure?",{"text":125,"@type":113},"Long-term evaluation did not show consistent associations for thiazides, ARBs, or ACE inhibitors, while weak associations were observed with calcium channel blocker duration and beta-blocker duration.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},335514,1790193405,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":46,"preview_page_count":4},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Original Article  \nLong-term exposure to antihypertensive drugs and the risk of cancer occurrence: evidence from a large population-based study  \nMatteo Franchia,b, Ginevra Torrigiania,b, Sverre Erik Kjeldsenc, Giuseppe Manciad,  \nand Giovanni Corraoa,d  \nObjective: Available data on the association between antihypertensive drugs and cancer are characterized by a few years follow-up. Our aim has been to evaluate the association between long-term exposure to antihypertensive drugs and the risk of cancer occurrence.  \nMethods: Using the healthcare utilization databases of the Lombardy region (Italy), individuals aged 40–85years who had no previous history of cancer and were newly dispensed with at least one antihypertensive drug from the major drug classes between 2009 and 2011 were followed from the first drug dispensation to December 31, 2020 . Data were analyzed according to the first drug used and the intention to treat principle, but also via an ‘‘as treated’’ approach, that is, by considering changes of and exposure to drugs during follow-up. The association between the duration of exposure to each drug class and the risk of cancer occurrence was evaluated using the adjusted Cox regression models.  \nResults: The study cohort included 338 910 new drug users (median age, 59years; 49 . 5% males) . During a median follow-up of 10 .2years, 36 556 cancers occurred. There was no consistent significant association between the risk of cancer occurrence and angiotensin-convertingenzyme inhibitors, angiotensin-receptor blockers, or thiazides. A progressive, weak increase in cancer occurrence was associated with progressive exposure to calcium channel blockers and, limited to long-term exposure, to beta-blockers. A modest progressive increase in risk was observed also for thiazide-like and loop diuretics in the as treated, although not in the intention to treat approach.  \nConclusions: Long-term evaluation of exposure to antihypertensive drugs did not show consistent associations between thiazides, angiotensin-receptor blockers, or angiotensin-converting-enzyme inhibitors and the risk of cancer occurrence. A weak association was observed between cancer and the duration of exposure to calcium channel blockers and beta-blockers.  \nKeywords: antihypertensive drugs, cancer, long-term  \nfollow-up, observational study, population-based Abbreviations: ACEIs, angiotensin converting enzyme inhibitors; ARBs, angiotensin receptor blockers; ATC,  \nanatomical therapeutic chemical; BBs, beta blockers; CCBs, calcium channel blockers; CI, confidence intervals; Ds, diuretics; HR, hazard ratios; ICD-9-CM, International Classification of Diseases, ninth revision, Clinical Modification; Loop D, loop diuretics; MCS, Multisource Comorbidity Score; RHS, Regional Health Service  \nBACKGROUND  \nT he association between antihypertensive drugs and  \nthe risk of cancer has been investigated in both  \nobservational studies and randomized treatment trials. Observational studies and their meta-analyses have provided variable results. Namely, while frequently concluding that exposure to antihypertensive drugs does not substantially modify the risk of cancer, these studies have also reported modest reductions and increases either in the overall cancer risk or in site-specific cancers [1–13], such in the case of thiazides and the increased risk of skin cancer [14–16] . In contrast, meta-analyses of randomized trials have usually concluded, in the context of a better comparability of antihypertensive drug users and controls, that major antihypertensive drug classes (diuretics, beta-blockers, angiotensin converting enzyme(ACE) inhibitors, angiotensin receptor antagonists, and calcium channel blockers) are associated with no or only a very modest change in the risk of cancer [17–22] . However, available data on the association between antihypertensive drugs and cancer risk have an important limitation,  \nJournal of Hypertension 2024, 42:2107–2114  \naNational Centre for He","cbCaio78xTILNFqz","https://ap.wps.com/l/cbCaio78xTILNFqz","pdf",704016,"English","# Objective\n# Methods\n# Results\n# Conclusions\n# Background","[{\"question\":\"What was the main aim of the study?\",\"answer\":\"To assess whether long-term exposure to antihypertensive drugs is associated with the risk of cancer occurrence, addressing limitations of shorter follow-up in prior evidence.\"},{\"question\":\"How were participants and drug exposure handled in the analysis?\",\"answer\":\"Individuals without prior cancer newly dispensed major antihypertensive drug classes (2009–2011) were followed to December 31, 2020, using both intention-to-treat and as-treated approaches that accounted for changes in exposure during follow-up.\"},{\"question\":\"Which antihypertensive drug classes showed associations with cancer risk?\",\"answer\":\"No consistent significant association was found for ACE inhibitors, ARBs, or thiazides. Weak progressive increases in cancer occurrence were linked to calcium channel blockers and, limited to long-term exposure, to beta-blockers; modest increases for some diuretics appeared only in the as-treated approach.\"},{\"question\":\"What conclusion did the authors draw about long-term exposure?\",\"answer\":\"Long-term evaluation did not show consistent associations for thiazides, ARBs, or ACE inhibitors, while weak associations were observed with calcium channel blocker duration and beta-blocker duration.\"}]","Long-term exposure to antihypertensive drugs and the risk of cancer occurrence - evidence from a large population-based study | PDF",1790011223]